Capitalmind Investec has advised the owners of Niutec on the sale to GBA Group.
About the deal
Capitalmind Investec acted as exclusive financial advisor to Niutec on the sale to GBA Group (GBA).
GBA is an international life science service company with over 3,000 employees, offering a wide range of analytical, logistical, and specialized services in the fields of pharmaceuticals, medical devices, cosmetics, chemicals, food, drinking water, and environmental analysis.
Niutec AG, founded in 2000 as a spin-off of the Sulzer Group, is one of Switzerland’s leading chemical testing laboratories, employing around 50 people today. The focus in the field of medical devices is on purity and biocompatibility testing, material testing and other technical services. In the environmental sector, Niutec offers specialized services for soil, waste, water, gas and air analyses.
Through the acquisition of Niutec, GBA expands its international laboratory network and is represented in Switzerland for the first time. With this acquisition, GBA is once again strengthening its positioning in the growing market for the qualification of medical devices. Furthermore, the partnership with Niutec creates a strong basis for further development in the important local Swiss market for environmental analysis.
What we did
The Capitalmind Investec team has advised the owners of Niutec throughout the entire M&A process to the successful closure of the transaction, including:
- Preparation of business plan and marketing materials
- Identification of potential buyers (strategic and financial)
- Market approach and realization of a competitive sales process
- Preparation and support of due diligence
- Designing an equity model for two senior employees
- Conducting price negotiations
- Support in negotiations of the legal documentation
- Coordination of all involved parties, incl. legal and tax advisors
